SecBot SecBot
144 ·Filed Nov 5, 2026

XERS

Xeris Biopharma Holdings, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed11d 11h ago SEC0001950047-26-010752
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is small relative to market cap and appears to be part of a pre-existing 10b5-1 plan for tax or diversification purposes. Monitor for any acceleration of insider selling beyond the plan's disclosed cadence.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$15.20
T+0 close · Nov 5, 2026 · via day close
Latest settled
+9.61%
T+5 · $16.66 · next T+20 in 20d
Vs SPY
+7.01%
α at T+5
Latest observation
+11.37%
T+6 · FF3 residual α
  1. T+0 · Nov 6 $15.20entry
  2. T+1 · 8d ago +4.34%α +1.98% · $15.86
  3. T+5 · 4d ago +9.61%α +7.01% · $16.66
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Kevin McCulloch, an officer of Xeris Biopharma, filed a Form 144 notice of intent to sell 25,000 shares of common stock with an estimated market value of $261,500. The shares were acquired through vesting of restricted stock units, and the filing references a 10b5-1 trading plan with prior sales under that plan in recent months.

Key Facts

  • Kevin McCulloch (Officer) filed Form 144 to sell 25,000 shares of common stock.
  • Estimated aggregate market value of the proposed sale is $261,500.
  • Shares were acquired upon vesting of restricted stock units from January 31, 2024 through January 31, 2025.
  • The filing references a 10b5-1 trading plan with prior sales on 09/01/2026, 09/28/2026, 10/01/2026, and 11/02/2026.
  • The proposed sale date is listed as 11/05/2026.

Financial Impact

Proposed sale of 25,000 shares valued at $261,500, representing approximately 0.014% of the company's $1.9B market cap.

dilution

Risk Factors

  • Insider selling, even under a 10b5-1 plan, can signal reduced conviction if it becomes more aggressive than historical patterns.
  • The filing is an intent to sell; the actual sale may not occur.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010752
Document: 0001950047-26-010752-index.html0001950047-26-010752
Document: 0001950047-26-010752.txt0001950047-26-010752

Track record

25 reports on XERS

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +45.52% at T+60 after the Aug 6, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $15.86 Now $16.70 +5.30% settles Dec 8
  2. Nov 5, 202611d ago 144 Neutral 2/10 Viewing Entry $15.20 Now $16.70 +9.87% settles Dec 7
  3. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
  4. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
  5. Nov 4, 202612d ago 3 Neutral 2/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
  6. Nov 2, 202614d ago 144 Neutral 2/10 Entry $10.35 Now $16.70 +61.35% settles Dec 2
  7. Nov 2, 202614d ago 8-K Neutral 2/10 Entry $10.17 Now $16.70 +64.21% settles Dec 1
  8. Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $10.71 Now $16.70 +55.93% settles Nov 30
  9. Oct 14, 20264w ago 8-K Neutral 3/10 Entry $9.77 to $16.52 Now $16.70 +70.93% ▲ +69.09% +70.36% vs SPY
  10. Oct 2, 20266w ago Insider Cluster Neutral 3/10 Entry $10.13 to $10.71 Now $16.70 +64.86% ▲ +5.73% +8.19% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens in 5h 44m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026